Adrian T. Dillon

Adrian T. Dillon is a declared insider at 2 companies (senior executive); the most frequent names are Healthequity, Inc. and Datto Holding Corp. Over a trading history stretching from 26 October 2021 to 25 August 2026, the count stands at 15 filings.

Market trades split into 2 purchases (€658k) and 2 sales (€684k). On balance, insiders were net sellers of €26k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 9 share grants and 1 option exercise. 2026 to date brings no purchases and 2 sales.

On 27 August 2026 came the latest disclosure, an option exercise for €213k in Healthequity, Inc. The last purchase on record was published on 15 December 2021, which is 1,768 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.